Unexpected intraoperative recognition of placenta accreta spectrum

Authors

  • Arti Amarshibhai Chavda Department of Obstetrics and Gynaecology, Mata Kaushalya Government Hospital, Patiala, Punjab, India https://orcid.org/0000-0003-4076-8113
  • Ramita Aggarawal Department of Obstetrics and Gynaecology, Mata Kaushalya Government Hospital, Patiala, Punjab, India
  • Sadhna Soni Department of Obstetrics and Gynaecology, Mata Kaushalya Government Hospital, Patiala, Punjab, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20232753

Keywords:

Placenta accreta spectrum, Pregnancy, Feto-maternal outcome, LSCS, Cesarean hysterectomy

Abstract

The worldwide incidence of placenta accreta spectrum (PAS) is increasing day by day, mostly due to the increasing trends in cesarean section rates. Although standard ultrasound is a reliable and primary tool for the diagnosis of placenta accreta, the absence of ultrasound findings does not preclude the diagnosis of placenta accreta. Therefore, clinical evaluation of risk factors is equally essential for the prediction of abnormal placental invasion. The accurate and timely diagnosis of placenta accreta is important to improve the feto-maternal outcome.

 

References

Cunningham FG, Leveno JK, Dashe SJ, Hoffman LB, Spong YC, Casey MB. Hemorrhagic Placental Disorders. In: Williams Obstetrics International. 26th edn. McGraw Hill Books 2022;43:759.

Levels of maternal care. Obstetric Care Consensus No. 2. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2015;125:502-15 .

Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine, Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Placenta Accreta Spectrum. Am J Obstet Gynecol. 2018;21U:B2-16.

Jauniaux El. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynecol Obstetr. 2018;140(3):265-73.

Illsley NP, DaSilva-Arnold SC, Al-Khan A, Zamudio S. Trophoblast invasion: Lessons from abnormally invasive placenta (placenta accreta), Placenta. 2020;1.

Bailit JL, Grobman W, Rice MM, Reddy UM, Wapner RJ, Varner MW et al. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol. 2015;125(3):683.

Shobeiri F, Jenabi E, Karami M, Karimi S. Determinants of placenta previa: a case-control study. Biomed Res Therapy. 2017;4:1411-U.

Meriem NADI, Placenta accreta: Case report presenting obstetric emergency. World Congress Gynecol Obstetr. 2020;1U-20.

Downloads

Published

2023-08-29

Issue

Section

Case Reports